Bank of America sees major upside in this biotech stock
A major Wall Street firm says a regulatory shift and coming launches could change the setup for one biosimilar developer.
Read the full story at TST (Full) - (Official Feed) →
A major Wall Street firm says a regulatory shift and coming launches could change the setup for one biosimilar developer.
Read the full story at TST (Full) - (Official Feed) →